Global Epinephrine Market Competitive Landscape, Top Market Segments, And Fastest Growing Regions
12 Jun, 2023
The global epinephrine market size is expected to grow from $2.20 billion in 2022 to $2.44 billion in 2023 at a compound annual growth rate (CAGR) of 11%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global epinephrine market size is expected to reach $3.49 billion in 2027 at a CAGR of 9.4%.
Global Epinephrine Market Key Driver
The rising frequency of chronic respiratory disorders is likely to drive the epinephrine market forward. Chronic respiratory disorders are medical conditions that affect the lungs and airways of the human body's respiratory system and have the potential to get an infection or develop a disease, which can lead to a number of consequences. Chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis are on the rise as a result of air pollution and adverse environmental, occupational, and behavioural inhalation exposures. Epinephrine is a critical medicine used to treat severe asthma attacks and anaphylactic responses, which can cause respiratory discomfort and potentially life-threatening complications.
Get a sample of the global epinephrine market reportGlobal Epinephrine Market Segments
The global epinephrine market is segmented:
1) By Type: Prefilled Syringe, Auto-injector, Ampoules and Vials
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications
4) By Geography: The regions covered in the epinephrine market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global epinephrine market.
Major Epinephrine Industry Players
ALK-Abelló A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Abbott Laboratories, Sanofi S.A., Viatris Inc., Lincoln Medical Ltd., Kaleo Inc., Gland Pharma Limited, Adamis Pharmaceuticals Corporation, Harvest Pharmaceuticals Inc., Merit Pharmaceutical
Get the full global epinephrine market report
Epinephrine Market Overview
Epinephrine, also known as adrenaline, is a hormone and neurotransmitter used for life-threatening allergic reaction treatment spurred by foods, medicines, latex, insect bites or stings, and other reactions treated with epinephrine injections along with emergency medical treatment.
Epinephrine Global Market Report 2023 provides data on the global epinephrine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The epinephrine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.